Amgen (AMGN) announces positive phase 3 DeLLphi-305 study, which met its primary endpoint when IMDELLTRA in combination with AstraZeneca's (AZN LN) Imfinzi

Newsquawk StaffPublished On the live feed at 7 more headlines followed before this page went public
Newsquawk headlinesUTC

Iranian army says a US MQ-1 drone has been shot down over Bandar Abbas, Tasnim reports

Daily US Equity Opening News: NVS sinks after phase 3 trial miss, peers also weighed; INTC upgraded; BE, P, ILMN to join SPX

Amgen (AMGN) announces positive phase 3 DeLLphi-305 study, which met its primary endpoint when IMDELLTRA in combination with AstraZeneca's (AZN LN) Imfinzi

GameStop (GME) Q2 2026 (USD): EPS 0.27 (prev. 0.25), Revenue 790.2mln (exp. 756.8mln)

Qualcomm (QCOM) announces a multi-generational pact with Amazon (AMZN) to build next-gen AI data centre infrastructure

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.

Related headlines

The whole workspace, free to try.

Try it free